Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines

被引:64
作者
Perego, P [1 ]
Corna, E [1 ]
De Cesare, M [1 ]
Gatti, L [1 ]
Polizzi, D [1 ]
Pratesi, G [1 ]
Supino, R [1 ]
Zunino, F [1 ]
机构
[1] Ist Nazl Tumori, I-20133 Milan, Italy
关键词
D O I
10.2174/0929867013373994
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular resistance to anthracyclines is a major limitation of their clinical use in the treatment of human tumors. Resistance to doxorubicin is described as a multifactorial phenomenon involving the overexpression of defense factors and alterations in drug-target interactions. Such changes do not account for all manifestations of drug resistance, in particular intrinsic resistance of solid tumors. Since anthracyclines can induce apoptotic cell death, an alternative promising approach to drug resistance has focused on the study of cellular response to drug-induced DNA damage, with particular reference to the relationship between cytotoxicity/antitumor efficacy and apoptotic response. The evidence that a novel disaccharide analog (MEN 10755), endowed with an improved preclinical activity over doxorubicin, was also more effective as an inducer of apoptosis provided additional insights to better understand the cellular processes that confer sensitivity to anthracyclines. Although the presence or alteration of a single apoptosis-related factor (e.g., p53, bcl-2) is not predictive of the sensitivity/resistance status, the complex interplay among DNA damage-activated pathways is likely an important determinant of tumor cell sensitivity to anthracyclines.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 23 条
[1]   Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients [J].
Aas, T ;
Borresen, AL ;
Geisler, S ;
SmithSorensen, B ;
Johnsen, H ;
Varhaug, JE ;
Akslen, LA ;
Lonning, PE .
NATURE MEDICINE, 1996, 2 (07) :811-814
[2]   Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress [J].
Amundson, SA ;
Myers, TG ;
Fornace, AJ .
ONCOGENE, 1998, 17 (25) :3287-3299
[3]   Doxorubicin disaccharide analogue: Apoptosis-related improvement of efficacy in vivo [J].
Arcamone, F ;
Animati, F ;
Berettoni, M ;
Bigioni, M ;
Capranico, G ;
Casazza, AM ;
Caserini, C ;
Cipollone, A ;
DeCesare, M ;
Franciotti, M ;
Lombardi, P ;
Madami, A ;
Manzini, S ;
Monteagudo, E ;
Polizzi, D ;
Pratesi, G ;
Righetti, SC ;
Salvatore, C ;
Supino, R ;
Zunino, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (16) :1217-1223
[4]  
Blagosklonny MV, 1998, INT J CANCER, V75, P933, DOI 10.1002/(SICI)1097-0215(19980316)75:6<933::AID-IJC17>3.0.CO
[5]  
2-3
[6]   Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts [J].
De Cesare, M ;
Pratesi, G ;
Giusti, A ;
Polizzi, D ;
Zunino, F .
BRITISH JOURNAL OF CANCER, 1998, 77 (03) :434-439
[7]   Mitochondria and apoptosis [J].
Green, DR ;
Reed, JC .
SCIENCE, 1998, 281 (5381) :1309-1312
[8]   Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies [J].
Harris, CC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) :1442-1455
[9]   Antitumor agent-induced apoptosis in myeloid leukemia cells:: A controlled suicide [J].
Jaffrézou, JP ;
Bettaïeb, A ;
Levade, T ;
Laurent, G .
LEUKEMIA & LYMPHOMA, 1998, 29 (5-6) :453-+
[10]   Cell death induced by topoisomerase-targeted drugs: more questions than answers [J].
Kaufmann, SH .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :195-211